Quest Diagnostics has inked a deal to perform confirmatory testing of positive breath samples from Hound Labs’ cannabis breathalyzer.
The deal establishes Quest as the exclusive provider of laboratory services for confirmatory testing, which will be done using its novel mass spectrometry technique.
Hound's breathalyzer isolates detection of THC (tetrahydrocannabinol), identifying cannabis used within hours of testing, and automatically processes results on-location within minutes. Negative test results indicate that an employee is not likely to have used cannabis immediately preceding or during the workday.
Hound Labs will begin delivering its breathalyzer in late 2022.
